Protalix BioTherapeutics (PLX) Change in Receivables (2010 - 2026)
Protalix BioTherapeutics' quarterly Change in Receivables came in at -$6.4 million in Q1 2026, down 381.67% year-on-year from $2.3 million in Q1 2025, and down 9.02% quarter-over-quarter from -$5.9 million in Q4 2025.
Protalix BioTherapeutics has reported Change in Receivables for 17 years, with the latest figure at -$6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 381.67% year-over-year to -$6.4 million; the trailing twelve-month figure through Mar 2026 stood at -$2.8 million (down 263.91% YoY), and the FY2025 full-year result was $5.9 million, up 354.21% from the prior year.
- Change in Receivables for Q1 2026 stood at -$6.4 million, down from -$5.9 million in the prior quarter.
- The five-year high for Change in Receivables was $7.1 million in Q2 2024, with the low at -$8.4 million in Q3 2024.
- Average Change in Receivables over 5 years is -$71352.9, with a median of $752000.0 recorded in 2024.
- Year-over-year, Change in Receivables soared 254.98% in 2023 and sank 881.65% in 2025.
- Tracing PLX's Change in Receivables over 5 years: stood at -$4.5 million in 2022, then increased by 16.41% to -$3.8 million in 2023, then soared by 120.0% to $752000.0 in 2024, then slumped by 881.65% to -$5.9 million in 2025, then decreased by 9.02% to -$6.4 million in 2026.
- The last three Change in Receivables figures came in at -$6.4 million (Q1 2026), -$5.9 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | -6.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.41 Mn |
| Mar 31, 2026 | -6.41 Mn |
| Dec 31, 2025 | -5.88 Mn |
| Dec 31, 2025 | -5.88 Mn |
| Sep 30, 2025 | 4.85 Mn |
| Sep 30, 2025 | 4.85 Mn |
| Jun 30, 2025 | 4.64 Mn |
| Jun 30, 2025 | 4.64 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 752,000.00 |
| Dec 31, 2024 | 752,000.00 |
| Sep 30, 2024 | -8.38 Mn |
| Sep 30, 2024 | -8.38 Mn |
| Jun 30, 2024 | 7.05 Mn |
| Jun 30, 2024 | 7.05 Mn |
| Mar 31, 2024 | -1.75 Mn |
| Mar 31, 2024 | -1.75 Mn |
| Dec 31, 2023 | -3.76 Mn |
| Dec 31, 2023 | -3.76 Mn |
| Sep 30, 2023 | 4.31 Mn |
| Sep 30, 2023 | 4.31 Mn |
| Jun 30, 2023 | 3.70 Mn |
| Jun 30, 2023 | 3.70 Mn |
| Mar 31, 2023 | -3.82 Mn |
| Mar 31, 2023 | -3.82 Mn |
| Dec 31, 2022 | -4.50 Mn |
| Dec 31, 2022 | -4.50 Mn |
| Sep 30, 2022 | 5.77 Mn |
| Sep 30, 2022 | 5.77 Mn |
| Jun 30, 2022 | -2.39 Mn |
| Jun 30, 2022 | -2.39 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | -3.04 Mn |
| Dec 31, 2021 | -3.04 Mn |
| Sep 30, 2021 | 2.49 Mn |
| Sep 30, 2021 | 2.49 Mn |
| Jun 30, 2021 | -695,000.00 |
| Jun 30, 2021 | -695,000.00 |
| Mar 31, 2021 | 2.28 Mn |
| Mar 31, 2021 | 2.28 Mn |
| Dec 31, 2020 | -1.31 Mn |
| Dec 31, 2020 | -1.31 Mn |
| Sep 30, 2020 | -2.40 Mn |
| Sep 30, 2020 | -2.40 Mn |
| Jun 30, 2020 | -2.47 Mn |
| Jun 30, 2020 | -2.47 Mn |
| Mar 31, 2020 | 4.09 Mn |
| Mar 31, 2020 | 4.09 Mn |
| Dec 31, 2019 | -4.96 Mn |
| Dec 31, 2019 | -4.96 Mn |
| Sep 30, 2019 | 1.96 Mn |
| Sep 30, 2019 | 1.96 Mn |
| Jun 30, 2019 | -797,000.00 |
| Jun 30, 2019 | -797,000.00 |
| Mar 31, 2019 | 3.61 Mn |
| Mar 31, 2019 | 3.61 Mn |
| Dec 31, 2018 | -562,000.00 |
| Dec 31, 2018 | -562,000.00 |
| Sep 30, 2018 | -328,000.00 |
| Sep 30, 2018 | -328,000.00 |
| Jun 30, 2018 | 477,000.00 |
| Jun 30, 2018 | 477,000.00 |
| Mar 31, 2018 | 3.51 Mn |
| Mar 31, 2018 | 3.51 Mn |
| Dec 31, 2017 | -6.49 Mn |
| Dec 31, 2017 | -6.49 Mn |
| Sep 30, 2017 | 2.93 Mn |
| Sep 30, 2017 | 2.93 Mn |
| Jun 30, 2017 | 446,000.00 |
| Jun 30, 2017 | 446,000.00 |
| Mar 31, 2017 | 3.09 Mn |
| Mar 31, 2017 | 3.09 Mn |
| Dec 31, 2016 | -225,000.00 |
| Dec 31, 2016 | -225,000.00 |
| Sep 30, 2016 | -3.59 Mn |
| Sep 30, 2016 | -3.59 Mn |
| Jun 30, 2016 | 3.74 Mn |
| Jun 30, 2016 | 3.74 Mn |
| Mar 31, 2016 | 1.22 Mn |
| Mar 31, 2016 | 1.22 Mn |
| Dec 31, 2015 | -2.36 Mn |
| Dec 31, 2015 | -2.36 Mn |
| Sep 30, 2015 | 1.85 Mn |
| Sep 30, 2015 | 1.85 Mn |
| Jun 30, 2015 | -814,000.00 |
| Jun 30, 2015 | -814,000.00 |
| Mar 31, 2015 | 803,000.00 |
| Mar 31, 2015 | 803,000.00 |
| Mar 31, 2014 | 744,000.00 |
| Mar 31, 2014 | 744,000.00 |
| Dec 31, 2013 | -3.04 Mn |
| Dec 31, 2013 | -3.04 Mn |
| Sep 30, 2013 | 392,000.00 |
| Sep 30, 2013 | 392,000.00 |
| Jun 30, 2013 | 364,000.00 |
| Jun 30, 2013 | 364,000.00 |
| Mar 31, 2013 | 42,000.00 |
| Mar 31, 2013 | 42,000.00 |
| Dec 31, 2012 | -2.34 Mn |
| Dec 31, 2012 | -2.34 Mn |
| Sep 30, 2012 | 1.64 Mn |
| Sep 30, 2012 | 1.64 Mn |
| Jun 30, 2012 | 1.73 Mn |
| Jun 30, 2012 | 1.73 Mn |
| Mar 31, 2012 | -1.27 Mn |
| Mar 31, 2012 | -1.27 Mn |
| Dec 31, 2011 | -1.08 Mn |
| Dec 31, 2011 | -1.08 Mn |
| Sep 30, 2011 | -761,000.00 |
| Sep 30, 2011 | -761,000.00 |
| Jun 30, 2011 | -3.70 Mn |
| Jun 30, 2011 | -3.70 Mn |
| Mar 31, 2011 | 1.65 Mn |
| Mar 31, 2011 | 1.65 Mn |
| Dec 31, 2010 | 1.76 Mn |
| Dec 31, 2010 | 1.76 Mn |
| Sep 30, 2010 | 3.39 Mn |
| Sep 30, 2010 | 3.39 Mn |